The FDA has given their approval to expand the use of Gardasil to include males. The vaccine, which provides protection against the human papillomavirus (HPV), is targeted for males ages 9 to 26. It will help prevent two strains of HPV known to cause genital warts in both men and women. The vaccine has not yet been included in the CDC's vaccine schedule for males, but it is likely to be included. Until Gardasil is included in the vaccine schedule, most insurance companies will not likely cover the cost of the vaccine, which is about $360. The good news is that the CDC is expected to meet next week to discuss Gardasil's inclusion, so there shouldn't be too long of a delay in getting males vaccinated.